Pancioli Named UC Chair of Emergency Medicine
CINCINNATI Arthur Pancioli, MD, has been appointed the Richard C. Levy Professor and chair of the department of emergency medicine at the University of Cincinnati College of Medicine. The appointment is effective Oct. 1 pending UC Board of Trustees approval.
Pancioli has been a professor of emergency medicine at UC since 2009 and has served as vice chair of the department since 2000. He joined the UC faculty after completing his emergency medicine residency at University Hospital/UC College of Medicine in 1995. He is a graduate of the University of Michigan Medical School.
"Dr. Pancioli is an outstanding clinician, researcher and administrator and we are fortunate to have someone of his caliber ready to assume these new responsibilities, said Andrew Filak, MD, acting interim dean of the College of Medicine and vice president for health affairs at UC.
Pancioli succeeds Brian Gibler, MD, chair of the department since 1995. Gibler has been named chief executive officer of UC Health University Hospital and senior vice president of UC Health.
Pancioli is a very active researcher with primary interest in acute ischemic stroke therapy. He is currently the principal investigator on a multi-center NIH-funded clinical trial of the combination of t-PA and eptifibatide for acute ischemic stroke therapy. A member of the Greater Cincinnati/Northern Kentucky Stroke Team since 1995, he also has held national leadership positions with the American Stroke Association and American Heart Association.
The department of emergency medicine includes 41 physicians who staff the emergency departments at University, Jewish and West Chester hospitals. The department was the first to offer an emergency medicine residency program in the United States. There are currently 48 residents in the four-year training program.
Arthur Pancioli, MD, (left) instructs resident Brent Gottesman, MD, in University Hospital's emergency department. He will serve as the principal investigator for the Cincinnati hub of a new neurological network.
Art Pancioli, MD, (right) works with a second-year resident to stablize a patient in the emergency department.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.